Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.
Yasuhiro EbiharaKiyoko KobayashiAkaru IshidaTomoya MaedaNaoki TakahashiYoshitada TajiNorio AsouKenji IkebuchiPublished in: Journal of clinical laboratory analysis (2017)
We conclude that PCT might provide additional information and could be used in combination with other biomarkers to detect infections in patients with hematological malignancies.
Keyphrases